Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > re b rate cut
View:
Post by sunshine7 on Apr 16, 2016 2:41pm

re b rate cut

As long as they demonstrate the ability to manage debt load from cash flow (as they have been doing), I see no reason to be concerned. Their cash flow seems to be approx 2x debt obligations even considering forex which was previously calculated to be minor issue.
Comment by Lattice on Apr 16, 2016 2:46pm
This post has been removed in accordance with Community Policy
Comment by Stockcoach1 on Apr 17, 2016 12:04pm
DUMBSTADIUM - Nothing but astrology. I can draw those lines in any direction I choose to create any image I please. Quit being a snake oil salesman and get on with the times.  You've just earned another ignore.  
Comment by Lattice on Apr 17, 2016 1:29pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities